{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:02Z","timestamp":1791908642856,"version":"4.3.4"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical &amp; Translational Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jcte.2020.100239","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T22:31:25Z","timestamp":1603837885000},"page":"100239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["An overview of Charcot\u2019s neuroarthropathy"],"prefix":"10.1016","volume":"22","author":[{"given":"Dured","family":"Dardari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2020.100239_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(99)90012-0","article-title":"Progress in care of the diabetic foot","volume":"354","author":"Edmonds","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jcte.2020.100239_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00000441-183108150-00004","article-title":"On a new practice in acute and chronic rheumatism","volume":"8","author":"Mitchell","year":"1831","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jcte.2020.100239_b0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00000441-183312240-00006","article-title":"Further cases and observations relative to rheumatism","volume":"12","author":"Mitchell","year":"1833","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.jcte.2020.100239_b0020","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00125-013-2961-6","article-title":"Who was first to diagnose and report neuropathic arthropathy of the foot and ankle: Jean-Martin Charcot or Herbert William Page?","volume":"56","author":"Sanders","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100239_b0025","article-title":"Charcot, le gentleman des p\u00f4les","author":"Heimermann","year":"1991","journal-title":"\u00c9ditions Ouest-France et du Pen-Duick"},{"key":"10.1016\/j.jcte.2020.100239_b0030","first-page":"161","article-title":"Sur quelques arthropathies qui paraissent dependre d\u2019une lesion du cerveau ou de la moelle epiniere","volume":"1","author":"Charcot","year":"1868","journal-title":"Arch Des Phys Norm et Pathol"},{"key":"10.1016\/j.jcte.2020.100239_b0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archinte.1936.00170060069004","article-title":"Neuritic manifestations in diabetes mellitus","volume":"57","author":"Jordan","year":"1936","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcte.2020.100239_b0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01241398-200001000-00018","article-title":"Charcot arthropathy in spina bifida","volume":"20","author":"Nagarkatti","year":"2000","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.jcte.2020.100239_b0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7547\/87507315-90-9-478","article-title":"Vincristine-induced neuroarthropathy (Charcot\u2019s joint)","volume":"90","author":"McKay","year":"2000","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jcte.2020.100239_b0050","doi-asserted-by":"crossref","unstructured":"Horibe S, Tada K, Nagano J. Neuroarthropathy of the foot in leprosy. J Bone Joint Surg Br 198c8;70:481\u20135.","DOI":"10.1302\/0301-620X.70B3.3372576"},{"key":"10.1016\/j.jcte.2020.100239_b0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7547\/87507315-85-6-318","article-title":"Charcot foot in an alcoholic patient. A case report","volume":"85","author":"Vera","year":"1995","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jcte.2020.100239_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-197205000-00006","article-title":"Neuroarthropathy (Charcot joints) in diabetes mellitus. Clinical study of 101 cases","volume":"51","author":"Sinha","year":"1972","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcte.2020.100239_b0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM194703132361103","article-title":"Neuropathic foot lesions in diabetes mellitus","volume":"236","author":"Bailey","year":"1947","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2020.100239_b0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.23.6.796","article-title":"Long-term follow-up in diabetic Charcot feet with spontaneous onset","volume":"23","author":"Fabrin","year":"2000","journal-title":"Diabet Care"},{"key":"10.1016\/j.jcte.2020.100239_b0075","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1002\/dme.1996.13.s1.52","article-title":"The Charcot neuroarthropathy joint in diabetes","volume":"13","author":"Klenerman","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-0030-1254525","article-title":"Neuro-osteoarthropathy of the foot-radiologist: friend or foe?","volume":"14","author":"Schoots","year":"2010","journal-title":"Semin Musculoskelet Radiol"},{"key":"10.1016\/j.jcte.2020.100239_b0085","doi-asserted-by":"crossref","unstructured":"Petrova NL, Edmonds ME. Acute Charcot neuro-osteoarthropathy Diabetes Metab Res Rev 2016;32:281\u20136.","DOI":"10.1002\/dmrr.2734"},{"key":"10.1016\/j.jcte.2020.100239_b0090","doi-asserted-by":"crossref","first-page":"21884","DOI":"10.3402\/dfa.v4i0.21884","article-title":"Charcot foot in diabetes and an update on imaging","volume":"4","author":"Ergen","year":"2013","journal-title":"Diabet Foot Ankle"},{"key":"10.1016\/j.jcte.2020.100239_b0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/107110078300400104","article-title":"Diabetic neuroarthropathy in the foot: patient characteristic and patterns of radiographic change","volume":"4","author":"Cofield","year":"1983","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jcte.2020.100239_b0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2214\/ajr.121.1.22","article-title":"Diabetic osteoarthropathy: clinical and roentgenographic observation in 90 cases","volume":"121","author":"Clouse","year":"1974","journal-title":"Am J Roentgenol Redium Ther Nucl Med"},{"key":"10.1016\/j.jcte.2020.100239_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1259\/0007-1285-68-805-27","article-title":"Organised chaos \u2013 computed evaluation of the neuropathic diabetic foot","volume":"68","author":"Griffiths","year":"1995","journal-title":"Br J Radiol."},{"key":"10.1016\/j.jcte.2020.100239_b0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO;2-8","article-title":"The natural history of acute Charcot\u2019s arthropathy in a diabetic foot speciality clinic","volume":"14","author":"Armstrong","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0115","unstructured":"Lomax, Gill A. Jones, Geraint R. The natural history of Charcot arthropathy in a stable diabetic population - 11 year review. Diabetes 2007; 56(suppl.1):A68\u2013A68. 1\/3p."},{"key":"10.1016\/j.jcte.2020.100239_b0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1056-8727(97)98004-1","article-title":"Change in major amputation rate in a centre dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation","volume":"12","author":"Faglia","year":"1998","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jcte.2020.100239_b0125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1464-5491.1995.tb00555.x","article-title":"Reduction of gangrene and amputations in diabetic renal transplant patients: the role of a special foot clinic","volume":"12","author":"Foster","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0130","first-page":"S12","article-title":"Knee neuroarthropathy in a patient with type I diabetes","volume":"15","author":"Lambert","year":"1998","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.jcte.2020.100239_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107438","article-title":"Multifocal (tarsus and knee) activation of neuroarthropathy following rapid glycaemic correction","volume":"33","author":"Dardari","year":"2019","journal-title":"J Diabet Complicat"},{"key":"10.1016\/j.jcte.2020.100239_b0140","doi-asserted-by":"crossref","DOI":"10.2337\/dc13-3045","article-title":"Diabetic Charcot neuroarthropathy of the knee: conservative treatment options as alternatives to surgery: case reports of three patients","volume":"37","author":"Illgner","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2020.100239_b0145","doi-asserted-by":"crossref","unstructured":"Patel A, Saini, Edmonds ME, Kavarthapu V. Neuropathic arthropathy of the Knee: Two case reports and a review of the literature. Case Reports in Orthopedics Volume 2018, Article ID 9301496, 8 pages.","DOI":"10.1155\/2018\/9301496"},{"key":"10.1016\/j.jcte.2020.100239_b0150","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2337\/diacare.28.4.984","article-title":"Charcot neuroarthropathy of the wrist in type 1 diabetes","volume":"28","author":"Lambert","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2020.100239_b0155","doi-asserted-by":"crossref","unstructured":"Rastogi A, Prakash M, and Bhansali A. Varied presentations and outcomes of Charcot neuroarthropathy in patients with diabetes mellitus International Journal of Diabetes in Developing Countries: Incorporating Diabetes Bulletin. 39(3):513-522.","DOI":"10.1007\/s13410-018-0700-8"},{"key":"10.1016\/j.jcte.2020.100239_b0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00003086-199812000-00016","article-title":"Diabetic Charcot\u2019s arthropathy of the wrist. Case report and literature review","volume":"357","author":"Bayne","year":"1998","journal-title":"Clinical Orthop"},{"key":"10.1016\/j.jcte.2020.100239_b0165","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1302\/0301-620X.79B5.0790742","article-title":"Charcot arthropathy after acetabular fracture","volume":"79","author":"Berg","year":"1997","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jcte.2020.100239_b0170","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/diacare.18.6.867","article-title":"Neuropathic arthropathy of the spine in diabetes","volume":"18","author":"Phillips","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2020.100239_b0175","series-title":"The high risk foot in diabetes mellitus","first-page":"297","article-title":"Diabetic neuropathic osteoarthropathy: The Charcot foot","author":"Sanders","year":"1991"},{"key":"10.1016\/j.jcte.2020.100239_b0180","first-page":"569","article-title":"The high risk foot in diabetes mellitus","author":"Frygberg","year":"1991","journal-title":"Churchill Livingstone"},{"key":"10.1016\/j.jcte.2020.100239_b0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1067-2516(99)80086-6","article-title":"Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient","volume":"38","author":"Sella","year":"1999","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jcte.2020.100239_b0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107110070502600109","article-title":"Current concepts review: Charcot neuroarthropathy of the foot and ankle","volume":"26","author":"Trepman","year":"2005","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jcte.2020.100239_b0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1056-8727(97)00080-9","article-title":"Normal blood flow response and vasomotion in the diabetic Charcot foot","volume":"12","author":"Shapiro","year":"1998","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jcte.2020.100239_b0200","unstructured":"Charcot J-M, F\u00e9r\u00e9 C. Affections osseuses et articulaires du pied chez les diab\u00e9tiques (pied diab\u00e9tique). ArchivesdeNeurologie6(18):305\u201319."},{"key":"10.1016\/j.jcte.2020.100239_b0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2337\/diacare.18.3.377","article-title":"Lower limb venous pressure in diabetic neuropathy","volume":"18","author":"Purewal","year":"1995","journal-title":"Diabet. Care"},{"key":"10.1016\/j.jcte.2020.100239_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00253862","article-title":"Blood flow in the diabetic neuropathic foot","volume":"22","author":"Edmonds","year":"1982","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100239_b0215","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/diabetes.47.3.457","article-title":"Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration","volume":"47","author":"Veves","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2020.100239_b0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000658-191708000-00011","article-title":"On the nature of neuropathic affections of the joint","volume":"66","author":"Eloesser","year":"1917","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcte.2020.100239_b0225","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2106\/00004623-198567040-00010","article-title":"Neurogenic acceleration of degenerative joint lesions","volume":"67A","author":"O\u2019Connor","year":"1985","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jcte.2020.100239_b0230","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jor.1100150420","article-title":"Selective ablation of rat knee joint innervation with injected immunotoxin: a potential new model for the study of neuropathic arthritis","volume":"15","author":"Salo","year":"1997","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jcte.2020.100239_b0235","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.1780330316","article-title":"Rapidly progressive Charcot arthropathy following minor joint trauma in patients with diabetic neuropathy","volume":"33","author":"Slowman-Kovacs","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcte.2020.100239_b0240","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00003086-199803000-00032","article-title":"Limb threatening neuropathic complications from ankle fractures in patients with diabetes","volume":"348","author":"Connolly","year":"1998","journal-title":"Clin Orthop"},{"key":"10.1016\/j.jcte.2020.100239_b0245","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/107110079401500405","article-title":"Fractures and dislocations of the foot and ankle in diabetics associated with Charcot joint changes","volume":"15","author":"Holmes","year":"1994","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jcte.2020.100239_b0250","first-page":"860","article-title":"Clinico-radiologic analysis of 115 cases","volume":"105","author":"Xu","year":"1992","journal-title":"Chin Med J (Engl.)"},{"key":"10.1016\/j.jcte.2020.100239_b0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1302\/0301-620X.79B5.0790753","article-title":"Wrist involvement in Hansen\u2019s disease","volume":"79","author":"Carpintero","year":"1997","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jcte.2020.100239_b0260","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1067-2516(98)80054-9","article-title":"Is Charcot arthropathy a late sequela of osteoporosis in patients with diabetes mellitus?","volume":"37","author":"Childs","year":"1998","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jcte.2020.100239_b0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.18.1.34","article-title":"Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy","volume":"18","author":"Young","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2020.100239_b0270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q","article-title":"Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy","volume":"14","author":"Gough","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0275","unstructured":"Piaggesi A, Marcocci C, Golia F, Gregorio S, Baccetti F, Navalesi R. Markers for Charcot\u2019s neurogenic Osteo-Arthropathy in diabetic patients. Abstract. Diabetes 29\/Suppl,1:A32."},{"key":"10.1016\/j.jcte.2020.100239_b0280","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11892-005-0050-z","article-title":"Theories concerning the pathogenesis of the acute Charcot foot suggest future therapy","volume":"5","author":"Jeffcoate","year":"2005","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jcte.2020.100239_b0285","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejps.2016.09.009","article-title":"A study of extracellular vesicle concentration in active diabetic Charcot neuroarthropathy","volume":"98","author":"Schara","year":"2017","journal-title":"Eur J Pharmaceut Sci"},{"issue":"2","key":"10.1016\/j.jcte.2020.100239_b0290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/dme.12590","article-title":"Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy","volume":"32","author":"Petrova","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0295","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/dc09-1141","article-title":"Pro-inflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot","volume":"33","author":"Uccioli","year":"2010","journal-title":"Diabet. Care"},{"issue":"6","key":"10.1016\/j.jcte.2020.100239_b0300","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.jfas.2018.03.023","article-title":"In Charcot pathogenesis A study of in vivo gene expression","volume":"57","author":"Connors","year":"2018","journal-title":"J Foot Ankle Surg"},{"issue":"6","key":"10.1016\/j.jcte.2020.100239_b0305","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00125-008-0992-1","article-title":"Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand","volume":"51","author":"Mabilleau","year":"2008","journal-title":"Diabetlogia"},{"issue":"4","key":"10.1016\/j.jcte.2020.100239_b0310","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/17453674.2015.1033606","article-title":"Role of Wnt\/\u03b2-catenin and RANKL\/OPG in bone healing of diabetic Charcot arthropathy patients","volume":"86","author":"Folestad","year":"2015","journal-title":"Acta Orthop."},{"key":"10.1016\/j.jcte.2020.100239_b0315","first-page":"7","article-title":"Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development","volume":"29","author":"Bruhn-Olszewska","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jcte.2020.100239_b0320","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7547\/0003-0538-104.5.522","article-title":"The development of a Charcot foot after significant weight loss in people with diabetes","volume":"104","author":"Murchison","year":"2014","journal-title":"Podiatr Med Assoc"},{"key":"10.1016\/j.jcte.2020.100239_b0325","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/TP.0b013e31825cadbb","article-title":"Charcot neuroarthropathy after simultaneous pancreas\u2013kidney transplant","volume":"94","author":"Rangel","year":"2012","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jcte.2020.100239_b0330","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/j.jfas.2018.09.022","article-title":"Development of Charcot neuroarthropathy in diabetic patients who received kidney or kidney-pancreas transplants","volume":"58","author":"Anthony","year":"2019","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jcte.2020.100239_b0335","doi-asserted-by":"crossref","unstructured":"Dardari D, Van GH, M'Bemba J, Laborne FX, Bourron O, Davaine JM, et al. Rapid glycemic regulation in poorly controlled patients living with diabetes, a new associated factor in the pathophysiology of Charcot's acute neuroarthropathy. PLoS One 2020 May 21.","DOI":"10.1371\/journal.pone.0233168"},{"key":"10.1016\/j.jcte.2020.100239_b0340","doi-asserted-by":"crossref","unstructured":"S\u00e4mann A, Pofahl S, Lehmann T, Voigt B, Victor S, M\u00f6ller F, et al. Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - long-term follow-up of 164 consecutive patients with 195 acute Charcot feet. Exp Clin Endocrinol Diabetes 2012;120(6):335\u20139. doi: 10.1055\/s-0031-1299705. Epub 2012 Mar 15.","DOI":"10.1055\/s-0031-1299705"},{"issue":"12","key":"10.1016\/j.jcte.2020.100239_b0345","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1464-5491.2008.02587.x","article-title":"Boulton Charcot neuroarthropathy triggered by osteomyelitis and\/or surgery","volume":"25","author":"Ndin","year":"2008","journal-title":"AJ Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0350","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00402547","article-title":"Selective neuropathy and preserved vascular responses in the diabetic Charcot foot","volume":"35","author":"Stevens","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100239_b0355","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1067-2516(97)80072-5","article-title":"Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon","volume":"36","author":"Grant","year":"1997","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jcte.2020.100239_b0360","unstructured":"Hough AJ, Sokoloff L. Pathology of osteoarthritis. In: McCarty DJ (ed.) Arthritis and Allied Conditions: A Textbook of Rheumatology. Lea & Febiger, Philadelphia, 1989. p.1571."},{"key":"10.1016\/j.jcte.2020.100239_b0365","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2106\/00004623-199803000-00009","article-title":"Elevated peak plantar pressures in patients who have Charcot arthropathy","volume":"80A","author":"Armstrong","year":"1998","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jcte.2020.100239_b0370","doi-asserted-by":"crossref","unstructured":"Rogers LC, Frykberg RG, Armstrong DG, Boulton AJM,Edmonds M, Van GH,et al. The Charcot foot in diabetes Diabetes Care 2011 Sep;34(9):2123\u20139.","DOI":"10.2337\/dc11-0844"},{"key":"10.1016\/j.jcte.2020.100239_b0375","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2337\/dc06-2168","article-title":"Is there a systemic inflammatory response in the acute Charcot foot?","volume":"30","author":"Petrova","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2020.100239_b0380","doi-asserted-by":"crossref","unstructured":"Chantelau E, Grutzner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wk Apr 24;144:w13948.","DOI":"10.4414\/smw.2014.13948"},{"key":"10.1016\/j.jcte.2020.100239_b0385","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1464-5491.2005.01677.x","article-title":"The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture","volume":"22","author":"Chantelau","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0390","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1464-5491.2010.03141.x","article-title":"The consequences of complacency: managing the effects of unrecognised Charcot feet","volume":"28","author":"Wukich","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2020.100239_b0395","doi-asserted-by":"crossref","unstructured":"Chantelau EA, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging \u2013 a review of 71 cases. Swiss Med Wk 2013:w13831.","DOI":"10.4414\/smw.2013.13831"},{"issue":"12","key":"10.1016\/j.jcte.2020.100239_b0400","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/MNM.0000000000000603","article-title":"Utility of PET\/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy","volume":"37","author":"Rastogi","year":"2016","journal-title":"Nuclear Med Commun"},{"key":"10.1016\/j.jcte.2020.100239_b0405","first-page":"10.3402\/","article-title":"An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy. Diabet","volume":"2","author":"Ramanujam","year":"2011","journal-title":"Foot Ankle"},{"key":"10.1016\/j.jcte.2020.100239_b0410","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1757-1146-6-30","article-title":"Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review","volume":"6","author":"Milne","year":"2013","journal-title":"J Foot Ankle Res"},{"key":"10.1016\/j.jcte.2020.100239_b0415","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/107110070502601101","article-title":"An analysis of iatrogenic complications from the total contact cast","volume":"26","author":"Guyton","year":"2005","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jcte.2020.100239_b0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1463-1326.2012.01671.x","article-title":"Medical management of Charcot arthropathy","volume":"15","author":"Petrova","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcte.2020.100239_b0425","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00402-006-0271-x","article-title":"\u201cSilent\u201d bone stress injuries in the feet of diabetic patients with polyneuropathy: a report on 12 cases","volume":"127","author":"Chantelau","year":"2007","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.jcte.2020.100239_b0430","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jdiacomp.2012.05.006","article-title":"Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable Walker","volume":"26","author":"Christensen","year":"2012","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jcte.2020.100239_b0435","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1056-8727(98)00006-3","article-title":"Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot location","volume":"12","author":"Sinacore","year":"1998","journal-title":"J Diabetes Complicat."},{"key":"10.1016\/j.jcte.2020.100239_b0440","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-011-2354-7","article-title":"Audit of acute Charcot's disease in the UK: the CDUK study","volume":"55","author":"Game","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100239_b0445","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/diacare.26.9.2595","article-title":"Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen","volume":"26","author":"Armstrong","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2020.100239_b0450","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1071100712464957","article-title":"Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment","volume":"34","author":"Osterhoff","year":"2013","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jcte.2020.100239_b0455","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","article-title":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial","volume":"44","author":"Jude","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100239_b0460","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.28.5.1214","article-title":"Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomised controlled trial","volume":"28","author":"Pitocco","year":"2005","journal-title":"Diabet Care"},{"key":"10.1016\/j.jcte.2020.100239_b0465","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.jfas.2004.07.005","article-title":"Bisphosphonates for the treatment of Charcot neuroarthropathy","volume":"43","author":"Anderson","year":"2004","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jcte.2020.100239_b0470","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/dc11-0396","article-title":"The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomised controlled trial","volume":"34","author":"Pakarinen","year":"2011","journal-title":"Diabet Care"},{"key":"10.1016\/j.jcte.2020.100239_b0475","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00125-012-2507-3","article-title":"Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature","volume":"55","author":"Richard","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100239_b0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2016.03.012","article-title":"Zoledronic acid increases the circulating soluble RANKL level in mice, with a further increase in lymphocyte-derived soluble RANKL in zoledronic acid- and glucocorticoid-treated mice stimulated with bacterial lipopolysaccharide","volume":"83","author":"Abe","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jcte.2020.100239_b0485","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/dc06-0376","article-title":"Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomised controlled trial","volume":"29","author":"Bem","year":"2006","journal-title":"Diabet Care"},{"key":"10.1016\/j.jcte.2020.100239_b0490","first-page":"S44","article-title":"The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on fracture healing in Charcot neuroarthropathy of lower extremity","volume":"16","author":"Brosky","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcte.2020.100239_b0495","article-title":"Treatment with parathyroid hormone does not enhance clinical resolution and fracture healing of Charcot osteoarthropathy: double blind randomised placebo controlled trial","volume":"985","author":"Petrova","year":"2016","journal-title":"Abstr EASD"},{"issue":"9","key":"10.1016\/j.jcte.2020.100239_b0500","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/1753-0407.12902","article-title":"Teriparatide (recombinant human parathyroid hormone [1-34]) increases foot bone remodelling in diabetic chronic Charcot neuroarthropathy: a randomised double-blind placebo-controlled study","volume":"11","author":"Rastogi","year":"2019","journal-title":"J Diabetes"},{"issue":"12","key":"10.1016\/j.jcte.2020.100239_b0505","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.2337\/dc19-1659","article-title":"Effect of methylprednisolone or zoledronic acid on resolution of active Charcot neuroarthropathy in diabetes: A randomised, double-blind, placebo-controlled study","volume":"42","author":"Das","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcte.2020.100239_b0510","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2337\/dc17-1517","article-title":"Nieuwdorp, Effect of single dose of RANKL antibody treatment on acute Charcot neuro-osteoarthropathy of the foot","volume":"41","author":"Busch-Westbroek","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2020.100239_b0515","article-title":"Preliminary (12-week) results from trial of Denosumab for acute diabetic Charcot neuroarthropathy","author":"Lau","year":"2017","journal-title":"Abstract Diabet Foot Australian Conf."},{"key":"10.1016\/j.jcte.2020.100239_b0520","doi-asserted-by":"crossref","unstructured":"Stefan H\u00f6pfner, Christoph Krolak, Stefan Kessler, Reinhold Tiling, Kirsten Brinkb\u00e4umer, Klaus Hahn, Stefan Dresel Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging Foot Ankle Int 2004 Dec;25(12).","DOI":"10.1177\/107110070402501208"},{"key":"10.1016\/j.jcte.2020.100239_b0525","article-title":"Wendy Hardeman Systematic review of techniques to monitor remission of acute Charcot neuroarthropathy in people with diabetes","volume":"21","author":"Gooday","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl. 5","key":"10.1016\/j.jcte.2020.100239_b0530","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1067-2516(07)60001-5","article-title":"American College of Foot and Ankle Surgeons. Diabetic foot disorders: a clinical practice guideline (2006 revision)","volume":"45","author":"Frykberg","year":"2006","journal-title":"J Foot Ankle Surg"},{"issue":"1","key":"10.1016\/j.jcte.2020.100239_b0535","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2337\/dc09-1497","article-title":"Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer","volume":"33","author":"Sohn","year":"2010","journal-title":"Diabet Care"},{"key":"10.1016\/j.jcte.2020.100239_b0540","doi-asserted-by":"crossref","unstructured":"Chaudhary S, Bhansali A, Rastogi, A. Mortality in Asian Indians with Charcot\u2019s neuroarthropathy: a nested cohort prospective study Acta Diabetologica 56(12):1259\u201364.","DOI":"10.1007\/s00592-019-01376-9"},{"issue":"5","key":"10.1016\/j.jcte.2020.100239_b0545","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2337\/dc08-1695","article-title":"Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone","volume":"32","author":"Sohn","year":"2009","journal-title":"Diabet Care"}],"container-title":["Journal of Clinical &amp; Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623720300922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623720300922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:57:00Z","timestamp":1762005420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623720300922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":109,"alternative-id":["S2214623720300922"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2020.100239","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of Charcot\u2019s neuroarthropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2020.100239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100239"}}